Baidu
map

A novel fixed-dose combination treatment for chronic hepatitis C, based on NS5A inhibitor fopitasvir and NS5B inhibitor sofosbuvir

Zhou, SY; Chen, XY; Chen, Y; Meng, NN; Tao, X; He, HL; Liu, ZH; Wang, NY; Yu, LT

Yu, LT (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu, Peoples R China.; Wang, NY (corresponding author), Southwest JiaoTong Univ, Sch Life Sci & Engn, Chengdu, Peoples R China.

PHARMAZIE, 2021; 76 (8): 372

Abstract

Drug resistance caused by the extreme genetic variability of zhe hepatitis C virus has rendered effective combinations of drugs indispensable in the t......

Full Text Link


Baidu
map
Baidu
map
Baidu
map